2016/07

Qualified and passed the Biotech and New Pharmaceutical Investment Plan by the Ministry of Economic Affairs

/by

2015/11

「aspicio™ Soft Hydrophobic Intraocular Lens」has obtained the NHI Code from the National Health Insurance Administration Ministry of Health and Welfare

/by

2015/07

Enterprise Resource Planning (ERP) has been implement

/by

2015/07

Obtained Vietnam approval of「aspicio™ Soft Hydrophobic Intraocular Lens」and 「lioli™ IOL Delivery System」

/by

2015/06

Obtained TFDA approval of 「aspicio™ Soft Hydrophobic Intraocular Lens」

/by

2015/04

First order of IOLs selling to the global market

/by

2015/04

Completed the acquisition of 100% AST Products, Inc. ( a US corporation) as our marketing and strategic partner

/by

2015/04

Obtained US FDA 510(k) clearance of「lioli™ IOL Delivery System」

/by

2015/03

Obtained TFDA approval of「lioli™ IOL Delivery System」

/by

2015/02

Applied US patent for「INJECTOR BARREL AND PLUNGER」

/by